Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.

Eloi DebourdeauHelene BeylerianVuong NguyenDaniel BarthelmesMark GilliesPierre Henry GabrielleStela VujosevicLouise OtooleMartin PuzoCatherine Creuzot-GarcherBenjamin WolffVincent Daiennull null

Published in: Ophthalmology and therapy (2024)

Eyes treated with a T&E regimen had better VA outcomes from VEGF inhibitors than eyes treated PRN. This large real-world data assessment supports previous data from randomized clinical trials that the T&E regimen delivers better outcomes than PRN.

Keyphrases

age related macular degeneration
clinical practice
optical coherence tomography
electronic health record
big data
endothelial cells
clinical trial
newly diagnosed
anti inflammatory
data analysis
metabolic syndrome
skeletal muscle